Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishnan Ramanathan

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
American Heart Journal|October 17, 2012
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entrySameer Bansilal, Michael E Farkouh, Whady Hueb, et al.
The American Journal of Cardiology|December 11, 2012
Biomarkers after risk stratification in acute chest pain (from the BRIC Study)Shiny Mathewkutty, Sanjum S Sethi, Ashish Aneja, et al.
Journal of Electrocardiology|May 7, 2020
Clinical assessment of AF pattern is poorly correlated with AF burden and post ablation outcomes: A CIRCA-DOSE sub-studyJason G Andrade, Robert R J Yao, Marc W Deyell, et al.
Circulation. Cardiovascular Quality and Outcomes|April 28, 2016
Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of StaySandra B Lauck, David A Wood, Jennifer Baumbusch, et al.
Journal of the American College of Cardiology|November 15, 2018
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On StudyMichael E Farkouh, Michael Domanski, George D Dangas, et al.
The American Journal of Cardiology|March 3, 2015
Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit)Ashish D Patel, Mary K Tan, Paul Angaran, et al.
Open Forum Infectious Diseases|June 10, 2024
The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 StudyJeff Kingsley, Nagalingeswaran Kumarasamy, Luis Abrishamian, et al.
The Canadian Journal of Cardiology|June 6, 2021
Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response TeamIan Paterson, Krishnan Ramanathan, Rakesh Aurora, et al.
The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.
European Heart Journal|April 27, 2007
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging studyVladimir Dzavík, Gad Cotter, Harmony R Reynolds, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
American Heart Journal|October 17, 2012
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entrySameer Bansilal, Michael E Farkouh, Whady Hueb, et al.
The American Journal of Cardiology|December 11, 2012
Biomarkers after risk stratification in acute chest pain (from the BRIC Study)Shiny Mathewkutty, Sanjum S Sethi, Ashish Aneja, et al.
Journal of Electrocardiology|May 7, 2020
Clinical assessment of AF pattern is poorly correlated with AF burden and post ablation outcomes: A CIRCA-DOSE sub-studyJason G Andrade, Robert R J Yao, Marc W Deyell, et al.
Circulation. Cardiovascular Quality and Outcomes|April 28, 2016
Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of StaySandra B Lauck, David A Wood, Jennifer Baumbusch, et al.
Journal of the American College of Cardiology|November 15, 2018
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On StudyMichael E Farkouh, Michael Domanski, George D Dangas, et al.
The American Journal of Cardiology|March 3, 2015
Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit)Ashish D Patel, Mary K Tan, Paul Angaran, et al.
Open Forum Infectious Diseases|June 10, 2024
The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 StudyJeff Kingsley, Nagalingeswaran Kumarasamy, Luis Abrishamian, et al.
The Canadian Journal of Cardiology|June 6, 2021
Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response TeamIan Paterson, Krishnan Ramanathan, Rakesh Aurora, et al.
The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.
European Heart Journal|April 27, 2007
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging studyVladimir Dzavík, Gad Cotter, Harmony R Reynolds, et al.
Pageof 7